Statistics

Total Visits

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study12

Select a period of time:

Number of views in the range

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study6

Views

Views
April 20242
May 20241
June 20240
July 20240
August 20243
September 20240
October 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Chicago1
Prineville1